Methods for stimulating granulocyte/macrophage lineage using thrombopoietin
Patent Number: 5989537
Date of First Priority Issue: Monday March 21st, 1994
Date Issued: Tuesday November 23rd, 1999
Assignee: ZymoGenetics, Inc. (Seattle, WA); University of Washington (Seattle, WA)
Inventors: Holly, Richard D. (Seattle, WA); Lok, Si (Seattle, WA); Foster, Donald C. (Seattle, WA); Hagen, Frederick S. (Seattle, WA); Kaushansky, Kenneth (Woodinville, WA); Kuijper, Joseph L. (Bothell, WA); Lofton-Day, Catherine E. (Brier, WA); Oort, Pieter J. (Sea
From Class: Expansion
Comments: No comments
As the name "thrombopoietin" implies, this cytokine is conventionally viewed as a stimulator of platelet production. In this patent the use of thrombopoietin for stimulation of the granulocytic/monocytic lineage is claimed. Currently numerous companies are developing agonists and agonistic antibodies of the thrombopoietin receptor.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.